Investors / Japan / Vision Incubate
Vision Incubate
Venture capital · Kanazawa, Japan · Asia Pacific
Vision Incubate supports ventures originating from national universities and operates venture capital funds. It is a registered professional fund operator and is headquartered at Kanazawa University's Innovation Creation Center.
Invests inHealthcare & Biotech
In its own wordsdeep techuniversity spinoutsacademiaregional ecosystembiotech
Your fit with Vision Incubate
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVision Incubate lists 6 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Series A, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (73%), Mobility & Logistics (9%) and AI & Machine Learning (9%). 88% of its companies are based in Japan. It invests most often alongside Beyond Next Ventures, Miyako Capital and Seiho Investment Works.
Counts come from funding rounds that name Vision Incubate, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundVision Incubate does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 67% |
| Series B | 33% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 98th | 33% of companies confirmed by a round |
| Sector focus | 92th | 73% in its largest sector |
| Reach | 42th | 2 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 73% | 15% |
| Mobility & Logistics | 9% | 1% |
| AI & Machine Learning | 9% | 18% |
| Industrial & Manufacturing | 9% | 7% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Beyond Next Ventures | 1 |
| Miyako Capital | 1 |
| Seiho Investment Works | 1 |
| UTokyo Innovation Platform | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Beyond Next Ventures
Compare Vision Incubate head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Vision Incubate| Date | Company | Stage |
|---|---|---|
| 28 Jul 2026 | Series A | |
| 13 May 2026 | Series B | |
| 19 Sept 2025 | Series A |
Round details for Vision Incubate
Amounts, full round histories and every co-investor in Vision Incubate's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Anaut develops and provides surgical assistance AI systems for medical use | Healthcare & Biotech | May 2026Series B | Page + round | |
| CORE Biomedicine develops cancer therapeutics that target core lineage dependencies in cancer cells. | Healthcare & Biotech | Jul 2026Series A | Page + round | |
| FerroptoCure is involved in treating diseases through ferroptosis. | Healthcare & Biotech | Sept 2025Series A | Page + round | |
| The company provides genetic analysis services and develops and manufactures reagent kits. | Healthcare & Biotech | Portfolio page | ||
| SFG SCIENCES develops new treatments for various diseases through scientific breakthroughs in drug discovery. | Healthcare & Biotech | Portfolio page | ||
| TEKMOF utilizes unique Metal Organic Frameworks to solve challenges across sciences and industries dealing with molecules | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- visionincubate.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 19 Sept 2025
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Vision Incubate's profile as data
Pull Vision Incubate's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/visionincubate.com
# also
GET /v1/firms/visionincubate.com/portfolio
GET /v1/firms/visionincubate.com/coinvestors
GET /v1/firms/visionincubate.com/news